Subscribe to Newsletter

Supply Chain

Business & Regulation Supply Chain

The Intersection of Sustainability

| Sreedhar Patnala | 3 min read

How pharmaceutical companies are aligning their sustainability goals with the complexities of the modern supply chain

Discovery & Development Ingredients

USP: A Mission Focused on Quality and Safety

| Chaitanya Koduri | 11 min read

Following on from deaths attributed to contaminated medicines, here’s how the US Pharmacopeia is promoting testing for DEG and EG.

Discovery & Development Ingredients

DEG Contamination: We Must Keep Eyes on Supply

| Stephanie Vine | 10 min read

As incidents of DEG poisoning continue to occur, the IPEC Federation issues a call for companies not to be complacent when it comes to supply chains.

Business & Regulation Standards & Regulation

Health Canada Unhappy with Florida’s Drug Importation Plans

| Stephanie Vine | 3 min read

As the Sunshine State looks to import medicines to lower costs for Floridians, what of ongoing shortages for Canadians?

Manufacture Advanced Medicine

In Support of the Supply Chain

| Fiona Withey | 7 min read

From automation to integration, there is huge room for improvement in supply chain management systems for cell and gene therapies

Business & Regulation Business Practice

Active Manufacturing Responsibility and the Other AMR

| Marijn Verhoef, Martijn van Gerven | 5 min read

Experts from the Access to Medicine Foundation discuss how to reduce the risk of antimicrobial resistance (AMR) in antibiotic manufacturing.

Business & Regulation Standards & Regulation

The Underworld of Counterfeit Fentanyl

| Jamie Irvine | 6 min read

A deep dive into the dangers of fentanyl entering the US supply chain – and the importance of the Drug Supply Chain Security Act

Manufacture Vaccines

The Shadow of COVID-19

| Stephanie Vine | 10 min read

How the European Commission has struck deals to secure manufacturing capacity for future emergencies.

Discovery & Development Ingredients

Manufacturers Urged to Take Steps to Avoid DEG and EG Contamination

| Stephanie Vine | 4 min read

Ongoing issues in the Asian pharma sector prompt an unequivocal response from the FDA and the IPEC Federation.

Manufacture Bioprocessing - Upstream & Downstream

Planes, Trains, and Autologous Therapies

| Sumukhi Sreevatsan | 3 min read

The potential of the cell and gene therapies sector depends – partially – on the expertise of the transport and logistics partners that complement it.


Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register